Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX)
$7.9900
+0.1400 ( -0.25% ) 367.0K
Amneal Pharmaceuticals Inc is a global pharmaceutical company operating primarily in the U.S., India, and Ireland. With three reportable segments; Generics, Specialty, and AvKARE - It develop, manufacture, and distribute a diverse portfolio of essential medicines. The Generics segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
Market Data
Open
$7.9900
Previous close
$7.8500
Volume
367.0K
Market cap
$2.47B
Day range
$7.5800 - $8.1000
52 week range
$5.0100 - $9.4750
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
10-q | Quarterly Reports | 102 | Aug 09, 2024 |
8-k | 8K-related | 16 | Aug 09, 2024 |
4 | Insider transactions | 1 | May 20, 2024 |
4 | Insider transactions | 1 | May 14, 2024 |
4 | Insider transactions | 1 | May 14, 2024 |
4 | Insider transactions | 1 | May 14, 2024 |